Recurrent/Refractory Secondary Central Nervous System Lymphoma
1 clinical trials · Condition
◉ Watch Recurrent/Refractory Secondary Central Nervous System Lymphoma
| Record | Firm | Date |
|---|---|---|
| Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL) (NCT02301364) | Memorial Sloan Kettering Cancer Center | 2014-11-20 |
Track Recurrent/Refractory Secondary Central Nervous System Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.